Parfum/Extrait de Parfum: At 25 to 40% fragrance concentrate, these are deep, rich, and designed to last all day with just a ...
Neuphoria Therapeutics (NEUP) announced that the AFFIRM-1 Phase 3 trial of BNC210 for the acute treatment of social anxiety disorder did not meet ...
Parfum/Extrait de Parfum: At 25 to 40% fragrance concentrate, these are deep, rich, and designed to last all day with just a dab. Eau de Parfum: The most popular strength for its staying power (around ...
AFFIRM-1 trial did not meet primary endpoint or secondary endpointsCompany to conduct strategic review of portfolio and business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results